Consun Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Consun Pharmaceutical Group has a total shareholder equity of CN¥4.0B and total debt of CN¥507.7M, which brings its debt-to-equity ratio to 12.7%. Its total assets and total liabilities are CN¥5.5B and CN¥1.5B respectively. Consun Pharmaceutical Group's EBIT is CN¥882.9M making its interest coverage ratio -16.8. It has cash and short-term investments of CN¥3.6B.
Key information
12.7%
Debt to equity ratio
CN¥507.70m
Debt
| Interest coverage ratio | -16.8x |
| Cash | CN¥3.58b |
| Equity | CN¥3.99b |
| Total liabilities | CN¥1.50b |
| Total assets | CN¥5.49b |
Recent financial health updates
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
Jun 12
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
May 04Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly
Apr 21Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly
Dec 18Recent updates
Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story
Oct 02Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors
Sep 26Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
Jun 12Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30
May 12Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30
Jun 01Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
May 04Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20
Apr 28Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20
Apr 07Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10
Aug 26Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly
Apr 21Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?
Mar 17Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative
Feb 19How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 29Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?
Jan 08
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly
Dec 18Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?
Nov 18Financial Position Analysis
Short Term Liabilities: 1681's short term assets (CN¥4.2B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 1681's short term assets (CN¥4.2B) exceed its long term liabilities (CN¥112.5M).
Debt to Equity History and Analysis
Debt Level: 1681 has more cash than its total debt.
Reducing Debt: 1681's debt to equity ratio has reduced from 27.7% to 12.7% over the past 5 years.
Debt Coverage: 1681's debt is well covered by operating cash flow (180.3%).
Interest Coverage: 1681 earns more interest than it pays, so coverage of interest payments is not a concern.